HomeMost PopularMedical Properties Trust Faces Uphill Battle Amid Challenging Market Conditions

Medical Properties Trust Faces Uphill Battle Amid Challenging Market Conditions

Actionable Trade Ideas

always free

Market graph on residential building background. Real estate index. Rising prices for purchase, sale and rental of flat. Housing. Investment trusts REITs. Construction industry. Japanese candles.

Investors had high hopes for Medical Properties Trust (NYSE:MPW) and similar net lease commercial REITs, viewing them as the gold standard for consistent payouts. However, recent events such as the pandemic and fast rate hikes have shattered those dreams, leaving MPW in a tough spot.

The Financial Grind: Analyzing Medical Properties Trust’s Real Estate Assets and Debt Covenants

Cutting Quality for Quantity: The Risky Business of Selling Assets

Many are celebrating, but with a lingering storm of financial worries swirling over MPW, it seems the ticker-tape parade might be dreadfully premature.

Risk factors are mounting and while MPW may seem to be as unyielding as an oak, the company’s covenants are weakening its financial stance.
One of the biggest concerns is the potential sale of assets lower than their actual worth, leading to a rapid decline in assets while liabilities remain stagnant. This dire situation could lead to a worrisome breach of covenants.

Cutting the Flowers and Watering the Weeds

Within the realm of asset sales, there is a gut-wrenching danger lurking in the shadows, coined as “cutting the flowers and watering the weeds” by investors. Should MPW go ahead with asset sales, they risk offloading high-quality properties while retaining lower-quality ones. The short-term appeal of such decision-making is overshadowed by the long-term peril it presents. The recent sale of properties in Australia exacerbates this issue, given that the properties sold were of superior quality, leaving MPW with a lopsided portfolio, heavily laden with precarious assets.

Valuation Incongruities

While some may extol the virtues of MPW, touting its share prices as a steal, it’s important to look beyond the fog of praise. Although P/FFO may appear tempting at 3.1, the allure of this apparently inexpensive valuation dissipates when evaluating the EV/EBITDA, which stands at a rather lofty 14.03.

The confounding contrast between EV/EBITDA versus P/FFO & P/CF is primarily attributed to MPW’s leverage. An exemplification of the impact of leverage lies in a comparison between a debt-free company trading at 10x EBITDA and a company laden with 8 turns of debt trading at 2x EBITDA. Despite the apparent variance, both companies equate to the same enterprise value, with the latter being burdened by a capital structure heavily reliant on debt.

The Bottom Line

As the pressure mounts, MPW is hurtling towards a cash flow negative future, necessitating asset liquidation. However, this path is fraught with pitfalls. Properties may fetch considerably less than their book value, and the haste to reduce debt might result in the disposal of high-quality assets, leaving the company shackled to high-risk properties. Contrary to popular belief, the supposed bargain in MPW’s valuation is unfounded, with an unattractive 14.03x EBITDA on the horizon.

The situation at present may be misleadingly rosy, but under the surface lies a thorny ordeal that could severely wound MPW’s financial health.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.